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Virulence factorStreptococcus pneumoniae (pneumococcus) infection causes more than 1.6 million deaths world-
wide. Pneumococcal growth is a prerequisite for its virulence and requires an appropriate supply
of cellular energy. Adenylate kinases constitute a major family of enzymes that regulate cellular
ATP levels. Some bacterial adenylate kinases (AdKs) are known to be critical for growth, but the
physiological effects of AdKs in pneumococci have been poorly understood at the molecular level.
Here, by crystallographic and functional studies, we report that the catalytic activity of adenylate
kinase from S. pneumoniae (SpAdK) serotype 2 D39 is essential for growth. We determined the crys-
tal structure of SpAdK in two conformations: ligand-free open form and closed in complex with a
two-substrate mimic inhibitor adenosine pentaphosphate (Ap5A). Crystallographic analysis of
SpAdK reveals Arg-89 as a key active site residue. We generated a conditional expression mutant
of pneumococcus in which the expression of the adk gene is tightly regulated by fucose. The expres-
sion level of adk correlates with growth rate. Expression of the wild-type adk gene in fucose-induc-
ible strains rescued a growth defect, but expression of the Arg-89 mutation did not. SpAdK increased
total cellular ATP levels. Furthermore, lack of functional SpAdK caused a growth defect in vivo.
Taken together, our results demonstrate that SpAdK is essential for pneumococcal growth in vitro
and in vivo.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Streptococcus pneumoniae (the pneumococcus), an encapsulated
Gram-positive, causes life-threatening infections (pneumonia, bac-
teremia, meningitis), and claims more than 1.6 million deaths
worldwide per year [1]. Streptococcal virulence is mediated by
many cell-surface virulence factors including capsular polysaccha-
rides and proteins as well as intracellular pneumolysin [2]. Never-
theless, survival and growth of pneumococci are prerequisites for
virulence.
ATP is involved in many cellular metabolic processes as a major
energy source, and could be a modulating factor for virulence [3].
Availability of the energy levels to living cells is dictated by ade-
nine nucleotide homeostasis. Thus, rigorous control of adeninenucleotide homeostasis is crucial to cellular metabolism. Adenyl-
ate energy charge (EC) in living cells is deﬁnded as follows [4]:
EC ¼ ½ATP þ 0:5 ½ADP½AMP þ ½ADP þ ½ATP
EC is the amount of energy readily accessible for cellular metab-
olism [4,5] that may affect other fundamental pathogenesis such as
bacterial growth, virulence factors, and secretion pathways [6,7].
Adenylate kinase (AdK; ATP:AMP phosphotransferase; EC
2.7.4.3) catalyzes conversion between adenylate nucleotides [8]:
Mg. ATP + AMPMMg. ADP + ADP. AdK has been attributed to the
synthesis and maintenance of adenine nucleotide homeostasis,
which is crucial in cellular viability and cell energy [8]. In Escheri-
chia coli, AdK is essential to cellular growth and survival, for regu-
lation of adenine nucleotide homeostasis [9]. However, it has
remained elusive as to whether AdK is essential in Gram-positive
bacteria. To explore the possibility that AdK from S. pneumoniae
(SpAdK) is crucial in pneumococcal growth by its catalytic activity,
we have undertaken structural and functional studies on SpAdK,
and investigated the effect of SpAdK on pneumococcal growth.
Fig. 1. Overview of SpAdK structure in two conformations. (A) SpAdK structure and its domains. (B) the crystal structure of SpAdK in complex with two mimic-substrates
(Ap5A); the ATP, AMP, LID and CORE domains are colored with cyan, marine, orange and forest, respectively; Ap5A is shown by stick-view. (C) The crystal structure of native
SpAdK, with ATP (light cyan), AMP (light blue), LID (light orange) and CORE (light green) domains. (D) The 2mFo-DFc electron density map at 1.48 A resolution shows the
Ap5A and cofactor Mg2+ (magenta sphere). (E) Superposition of two structures. (F) An insight view of the two mimic-substrate-binding cleft, including Mg2+ (magenta sphere),
and 4 water molecules (red spheres). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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2.1. Crystal structure of adenylate kinase from S. pneumoniae in two
conformations
SpAdK consists largely of core, nucleotide binding and lid
domains (Fig. 1A). The nucleotide-binding domain is furtherdivided into ATP and AMP binding domains. The crystal structures
of SpAdK were determined in two conformations: inhibitor-bound
closed form at 1.48 Å, and ligand-free, open form at 1.69 Å resolu-
tion (Fig. 1B and C). Both structures were deposited in the Protein
Data Bank under the accession codes PDB: 4NU0 (closed structure
with Ap5A) and PBD: 4NTZ (open structure).The overall folding of
SpAdK features a typical a/b class structure, where a-helices wrap
674 T.T. Thach et al. / FEBS Open Bio 4 (2014) 672–682around a central b-sheet region (Figs. 1B and C). The lid and core
domains, as well as P-loop, form an ATP binding pocket; mean-
while, AMP binds to the pocket formed by the core and AMP
domains. The lid and AMP domains can access the substrate-bind-
ing site in the open form, which is consistent with previous reports
[10,11]. P1, P5-di(adenosine-50) pentaphosphate (Ap5A), a
two-substrate mimicking inhibitor, was well deﬁned in the closed
conformation (Fig. 1D). Structural comparison between the two
conformations showed signiﬁcant changes, in which both the lid
and AMP domains move closer to the active site, allowing substrate
access, in reference to the core domain (Fig. 1E). Superposition of
each domain between the two conformations revealed that the
lid domain shows the most variation, with 1.6 Å of r.m.s.d., sup-
porting domain movement.
2.2. Structural comparison to known bacterial AdKs
The overall SpAdK structure is similar to those of other AdKs,
with noticeable differences in the lid domain (Fig. 2). The superpo-
sition of open conformation structures from SpAdK, E. coli (Ec),
Aquifex aeolicus (Aa), Desulfovibrio gigas (Dg), and Homo sapiens
(Hs) using Dali server [12] showed signiﬁcant differences in the
higher mobile loops in the lid domain (Fig. 2A). For instance, the
r.m.s.d. between Ca atoms from SpAdK and 4AKE (E. coli) structure
is 3.2 Å. The number of residues in the lid domain is also different
from other AdKs. Consistently, the sequence alignment from
SpAdK and other AdKs shows the N-terminal region including P-
loop (residues 7–16) is strictly conserved, whereas the lid domain
and C-terminal region are variable (Fig. 2B). Interestingly, SpAdK
does not contain a conserved metal-binding motif (Cys-X2-Cys-
X16-Cys) in the lid domain [13].
2.3. Arg-89 is the most important residue for catalytic activity
The active site of SpAdK features several conserved Arg residues
(Fig. 1F). The strictly conserved Arg-89 forms hydrogen bonds with
oxygen atoms, in both the d- and e-phosphate group of Ap5A. The
e-phosphate group of Ap5A corresponds to the phosphate group of
AMP. The hydrogen bond network among Arg-89, Glu-93, and Asp-
61 is known to serve as a backbone in the catalysis and AMP
domain rearrangements [14]. Moreover, Arg-89 is a part of the con-
served G(Y/F)PR motif stabilizing AdK structure, and transferring a
phosphate group from ATP to AMP [15]. Two other Arg residues,
Arg-36 and Arg-128 form hydrogen bonds with oxygen atoms of
the phosphate groups in Ap5A. Gly-86 recognizes adenine base of
Ap5A, by forming hydrogen bond with N6b. Tyr-87 is roughly par-
allel to an adenine moiety of Ap5A, without apparent hydrogen
bond formation. Magnesium ion is found to be coordinated by four
water molecules, as well as oxygen atoms from the b- and c-phos-
phate of Ap5A, in the active site of the closed SpAdK:Ap5A struc-
ture. Lys-13 is located in the P-loop, and known to form
hydrogen bonds with oxygen atoms from the phosphate groups
of ATP and AMP [15]. In our SpAdK:Ap5A structure, Nf forms a
hydrogen bond with oxygen atom from the d-phosphate group of
Ap5A (3.2 Å), but is a little bit distant from the O3c of Ap5A
(3.9 Å) for hydrogen bonding to occur.
To assess the catalytic roles of the active site residues, the cat-
alytic activities of eight SpAdK mutated proteins were measured
(Fig. 3). Since AdKs catalyze both ATP formation and hydrolysis
[16], the catalytic activities of both directions were measured.
Among the mutated proteins tested, mutation at Arg-89 most sig-
niﬁcantly deteriorated the activity. We tested both R89A and R89G,
because previous studies suggested that mutating Arg to Ala or Gly
was efﬁcient, in reducing the catalytic activity [17,18]. For SpAdK,
both R89A and R89G exhibited comparable reduction in activity.
Since all the eight residues subject to mutagenesis were mutatedto Ala, we used R89A for subsequent functional studies. Taken
together, our results establish that Arg-89 is a critical residue for
the catalytic activity of SpAdK.
2.4. SpAdK deﬁciency abolishes pneumococcal growth
To determine the role of SpAdK in pneumococcal growth, we
generated adk mutant, in either serotype 2 encapsulated D39 (S
type), or non-encapsulated CP1200 (R type). However, these adk
mutant strains were not viable, implying that SpAdK protein is
essential. Hence, we generated a fucose-inducible strain, which
permits conditional expression of adk in S. pneumoniae. We fused
a fucose promoter with the adk open reading frame, thus express-
ing adk gene only in the presence of fucose (Fig. 4 and Table 2). In S.
pneumoniae D39, the adk gene (spd_0214) is ﬂanked by upstream
secY (spd_0213) and by downstream infA (spd_0215) genes. The
639 bp of the adk open reading frame is ﬂanked by 150 bp and
118 bp intergenic regions at the 50 and 30 ends, respectively. Tran-
scription of the adk is not affected by the upstream gene secY nor
the erythromycin resistance cassette (ermAM) owing to the tran-
scription terminators at up- and down-stream of the adk gene to
prevent transcription from either end (Fig. 4A). A bacterial r70 pro-
moter recognition program, BPROM [19], showed that putative pro-
moters of the secY, adk, and infA genes are located in the upstream
of these genes in the same orientation (Fig. 4B), suggesting that the
adk and infA genes are transcribed independently. To conﬁrm that
fucose could regulate only adk transcription and not the ﬂanking
genes, total RNA was extracted in the presence of various concen-
trations of fucose and used for determination of mRNA level of the
ﬂanking genes by reverse transcription PCR (RT-PCR). RT-PCR data
showed that secY and ifnA expression was not affected by fucose
concentration (Fig. 4C), suggesting that fucose induces speciﬁcally
adk expression but not its ﬂanking genes and adk transcription
does not affect expression of the ﬂanking genes. Therefore, in our
experimental system, adk was transcribed as a monocistronic.
We examined the effect of adk expression on pneumococcal
growth using the aforementioned fucose-inducible expression sys-
tem (Fig. 5). In the absence of L-()-fucose (fucose), pneumococcal
growth was arrested. However, after supplementation of various
concentrations of fucose into the culture, a good correlation
between fucose concentration and level of the SpAdK was demon-
strated (Fig. 5A). Higher fucose concentration gave rise to higher
growth rate in the fucose-inducible strains, while the growth rates
of both S (encapsulated) and R (non-encapsulated) wild-types
(WTs) were not affected by the presence of fucose (Fig. 5B). At
0.1% fucose concentration where the expression level of adk is
low, encapsulated D39 fucose-inducible adk strain (TTL01) showed
lower growth rate (Fig. 5B-left), than the non-encapsulated CP1200
adk mutant (TTL04) (Fig. 5B-right). This observation implies that
0.1% fucose could generate enough ATP for R type mutant for
growth, but not for S type mutant. We speculate that at 0.1%
fucose, S type TTL01 could not produce enough ATP for growth,
most likely due to the requirement of ATP for capsular polysaccha-
ride synthesis. This result supports that SpAdK is essential for
growth. Notably, SpAdK expression was also higher at log-phase,
than the other phases (Fig. 5C), which supports the idea that SpAdK
provides ATP for cellular activities. Supplementation of goat serum
induced SpAdK level dose-dependently and pneumococcal growth
(Fig. 5D), strongly implying the relationship between SpAdK
expression and pneumococcal growth.
To further conﬁrm the role of SpAdK in pneumococcal growth,
pMV158 containing the WT adk gene or adk-R89A mutation was
introduced into the adk inducible strains, and the requirement of
SpAdK for growth was analyzed. When the WT adk gene was intro-
duced into the adk inducible strains of S type (TTL01) and R type
(TTL04), the resulting complemented strains (TTL02 and TTL05,
Fig. 2. (A) Secondary structure-based sequence alignment. (B) Structural superposition of SpAdK with AdKs from Bacillus subtilis (Bs), Escherichia coli (Ec); Aquifex aeolicus
(Aa); Desulfovibrio gigas (Dg) and Homo sapiens (Hs). Conserved residues are labeled in black; arrows indicate the site-directed mutagenesis points.
Fig. 3. Activity assay of SpAdK mutated proteins. ADP production assay (black bars)
and ATP production assay (tilted gray bars) are shown. One-letter amino acid codes
are used. Relative activities in reference to the wild type (WT) are shown.
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introduction of the R89A mutation to the adk inducible strains
(TTL03 and TTL06) showed growth defect, and did not growwithout fucose (Fig. 6). Collectively, these results demonstrate that
SpAdK is essential for pneumococcal growth.
2.5. SpAdK increases intracellular ATP
Since AdK modulates ATP synthesis until ADP and ATP levels
reach equilibrium, high concentration of fucose should produce
high SpAdK activity, resulting in a higher level of ATP. Fucose
was added into culture of the TTL01, and the intracellular ATP level
was determined. At 1.0% fucose, the intracellular ATP level of the
TTL01 strain was increased more than that of the D39 WT or
TTL01 at 0.1% fucose, although the fucose itself did not affect the
intracellular ATP level of the D39 WT (Fig. 7). These data consis-
tently suggested that SpAdK is essential for ATP synthesis.
2.6. Lack of functional SpAdK attenuates pneumococcal growth in vivo
Since SpAdK plays an essential role in pneumococcal growth
and ATP synthesis, role of SpAdK in virulence was determined
in vivo. Prior to infection, the TTL01 strain was incubated in 0.5%
fucose, and then administrated to mice via intranasal (i.n.) or intra-
peritoneal (i.p.) route (1.5  107 CFU per mice). Results showed
that the mice infected with the TTL01 survived much longer than
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(Fig. 8A). In particular, no mice were survived after infection i.p.
with D39 WT at 30 h post-infection whereas all the mice were sur-
vived after infection with the TTL01. Consistently, 5 mice survived
at 14 days post-infection once 14 were infected i.n. with D39 WT
initially (5/14) while 13 survied once 15 were infected i.n. with
the TTL01 (13/15). Moreover, a lower infection dose was also per-
formed: after 1.5  104 CFU per mice i.p. and 1.5  106 CFU per
mice i.n. infections, survival percentage of the mice infected with
the TTL01, particularly 4/5 (80%) (i.p.) and 2/5 (40%) (i.n.), was also
signiﬁcantly higher than that of the mice infected with the WT
demonstrating that the TTL01 mutant was unable to survive
in vivo (Fig. 8B). Moreover, the number of viable cells of the
TTL01 infection recovered from mice blood was 107 and 108-fold
lower, than those of the D39 WT respectively (Fig. 8C), after i.p.
and i.n. infections, indicating that the viability of the TTL01 is dra-
matically decreased, compared to that of the D39 WT, in vivo.
3. Discussion
ATP is a pivotal metabolic intermediate required for cell growth.
Although AdK is not an ATP synthase, it reversely catalyzes two
molecules of ADP to AMP and ATP. Since inactivation of AdK in
E. coli decreased the rate of macromolecular synthesis [20], AdKseems to control cell growth via cellular energy homeostasis. How-
ever, the role of AdK of Gram-positive bacteria in normal growth
has not been characterized yet. In this study, we found that an iso-
genic adk deletion mutant of S. pneumoniae was not viable. Thus, a
conditional mutant using fucose inducible adk promoter was con-
structed, and correlationship between fucose concentration and
growth rate was demonstrated. Moreover, dependence of pneumo-
coccal growth on SpAdK was corroborated using complementation
test and mutational studies with R89A (Figs. 5 and 6). Consistently,
the fucose-dependent adk strain (TTL01) showed reduced viability
in vivo (Fig. 8).
Although there are more than 90 serotypes of pneumococci,
BLAST search results showed that strains of various serotypes show
highly conserved adk sequence. The adk gene of the D39 strain
(type 2) shares 100% homology with the R6 strain as well as sero-
types 1 (INV104 and P1031 strains), 6B (670-6B), 15B (Nether-
lands15B-37), A19 (TCH8431), 19A (Hungary19A-6), 19F
(Taiwan19F-14), and 23F (ATCC 700669), and 99% homology with
serotypes 3 (OXC141 strain), 4 (TIGR4), 14 (INV200) and 19F
(CGSP14 and G54), showing that adk gene is highly conserved
across the serotypes of S. pneumoniae. From these results, it is
understood that so long as it has high sequence homology between
serotypes or strains of S. pneumoniae, the adk gene can be a useful
target for inactivating or modulating the SpAdK activity to develop
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known: cytoplasmic AdK1 (GenBank ID: 4502011) and AdK5
(GeneBank ID: 257051028), and mitochondrial AdK2 (GenBank
ID: 14424799), AdK3 (GenBank ID: 6518533), AdK4 (GeneBankID: 125157), and nuclear AdK6 (GeneBank ID: 4507351) [21].
Except human AdK6, SpAdK is homologous to human AdKs at pri-
mary sequence level: 29%, 39%, 37%, 35%, and 29% sequence iden-
tity for AdK1, AdK2, AdK3, AdK4, and AdK5, respectively. Although
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residues and tertiary structure of human AdKs appear to be con-
served as exempliﬁed by human AdK2 (Fig. 2). Therefore, interven-
tion of AdK activity for chemotherapeutics development should be
based on allosteric modulation of SpAdK rather than direct inter-
ference with the active site.AdK has been implicated in the pathogenesis in Gram-negative
bacteria but not known in Gram-positive bacteria. For instance,
AdK is secreted by the pathogenic Gram-negative strains of Pseudo-
monas aeruginosa and Burkholderia cepacia during infection and
causes macrophage or mast cell death [7,22,23]. AdK secretion
from pathogenic B. cepacia is speciﬁcally activated by eukaryotic
protein a2-macroglobulin [22]. Pathogenic mucoid P. aeruginosa
strains can increase the external ATP levels and kill macrophage
via activation of P2Z receptor [23], which is responsible for pore
formation on macrophage membrane [7,22,23]. Furthermore, at
the site of inﬂammation, ATP concentration can be reached as high
as hundreds micromolar [24], and ATP released by invading patho-
gens works as extracellular messengers and can be recognized
readily by P2 receptors in innate immune cells. Although pneumo-
coccal SpAdK was not secreted during infection (data not shown),
our result does not rule out the possibility that pneumococcus
would be lysed after invasion into the host cells resulting in release
of SpAdK as well as nucleotides.
To adapt to hostile environments within the host, pathogenic
bacteria can activate their virulence regulators via stringent signal
responses mediated by guanosine 50-diphosphate-30-diphosphate
(ppGpp) and guanosine 50-triphosphate-30-diphosphate
((p)ppGpp) [25]. The ppGpp mediates many physiological effects
by direct or indirect control of transcription [25]. The ppGpp level
in bacteria is modulated by both monofunctional synthetase RelA
and bifunctional synthetase/hydrolase SpoT and RSH (RelA/SpoT
homologue) proteins [25]. Both type of enzymes synthesize ppGpp
from GDP or GTP, and by pyrophosphoryl transfer from ATP [26].
Most Gram-negative bacteria encode both RelA and SpoT whereas
S. pneumoniae, a Gram-positive, encodes a bifunctional RSH protein
RelSpn and a RelA-like synthetase homologue RelQ. In enterohem-
orrhagic E. coli, accumulation of ppGpp by RelA induction leads
to the increased gene expression in the locus of enterocyte efface-
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infected i.p. or i.n. with approximately 1.5  104 CFU or 1.5  106 CFU of D39 or TTL01 (n = 5), and survival time was monitored for 24 h or 48 h for i.p. and i.n. infections,
respectively. (C) Group of mice was infected i.p.with 1.5  104 or i.n.with 1.5  106 CFU of either D39 or TTL01 for 24 h (i.p.) or 48 h (i.n.), and number of viable bacteria in the
blood was determined either 24 h (i.p.) or 48 h (i.n.) post infection after sacriﬁce, if they were alive, or post-mortem (n = 3–5).
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pneumoniae type 2 D39, RelSpn up-regulates the expression of
pneumolysin (ply), a major pneumococcal virulence factor [28].
Since SpAdK regulates S. pneumoniae type 2 ATP level (Fig. 7) and
ATP is pivotal for ppGpp metabolism, SpAdK might be involved
in the pneumoccocal virulence. Therefore, further works on SpAdK
virulence or cytotoxicity would warrant how SpAdK modulates
cytotoxicity or virulence.
In this study, we investigated the structure and function of
SpAdk, both in vitro and in vivo. We found SpAdK to be essential
in pneumococcal growth. Cellular ATP levels increase in proportion
to the SpAdK level, establishing that SpAdK is involved in energy
homeostasis. The adk mutant showed defective growth in vitro
and in vivo. Taken together, our results demonstrate that SpAdK
is essential for pneumococcal growth.
4. Materials and methods
4.1. Cloning and mutagenesis
Gene encoding AdK in S. pneumoniae D39 (accession number,
NC_008533.1) was ampliﬁed and inserted into parallel His2 paral-
lel vector [29] between BamHI and EcoRI restriction enzyme sites.
All plasmids containing mutated sequences were generated using
Quikchange II site-directed mutagenesis kit (Agilent Technologies),
and then conﬁrmed by DNA sequencing. E. coli strains were cul-tured in Luria Broth (LB) medium. Extraction and puriﬁcation of
plasmid DNAs from E. coli were performed using Qiagen kit
(Qiagen).
4.2. Protein puriﬁcation and crystallization
All proteins were expressed in E. coli BL21 (DE3) strain and puri-
ﬁed by afﬁnity chromatography on Ni–NTA resin (Qiagen). His-tag
was cleaved using tobacco etch virus protease [30] by dialysis
against buffer A (25 mM Tris–HCl pH 7.5, 75 mM NaCl, 1 mM
MgCl2 and 50 mM EDTA) overnight at 20 C. The protein was fur-
ther puriﬁed on Superdex-75 size exclusion column (GE Health-
Care) equilibrated with buffer B (50 mM Tris–HCl pH 7.5,
150 mM NaCl, 1 mM MgCl2). Fractions containing pure AdK were
pooled and concentrated by 10 kDa-centrifugal ﬁlters (Ambicom).
Protein monodispersity was checked by dynamic light scattering
measurement on DynaPro 100 (Protein Solutions) in the buffer B.
Crystallization of SpAdK and SpAdK:Ap5A was attempted at
22 C, by the hanging-drop vapor-diffusion method. SpAdK crystals
were obtained by mixing 2.5 ll 18 mg/ml protein solution with
2.5 ll reservoir solution containing 2.0 M (NH4)2SO4, 0.1 M CHES
pH 9.5, 0.2 M Li2SO4, and 0.1 M CsCl2. SpAdk:Ap5A crystals
appeared in the reservoir containing 0.1 M sodium acetate, 0.1 M
sodium acetate pH 4.6, 30% PEG 8 K, and 50 mM NaF. The crystals
were transferred to a cryoprotectant solution containing 22.0 and
27.5% glycerol for SpAdK and SpAdK:Ap5A, respectively.
Table 1
Crystallographic data collection and reﬁnement statistics.
Conformation ligand Closed Ap5A Open
Data collection
Space group P1 P21
Cell dimensions
a, b, c (Å) 39.20, 48.34, 52.57 44.22, 53.7, 50.87
a, b, c () 75.30, 72.95, 88.77 90, 114.46, 90
Resolution (Å) 1.48 (1.51–1.48)* 1.70 (1.73 – 1.70)
Rr.i.m.
a 0.070 (0.304) 0.093 (0.104)
Rp.i.m.
a 0.049 (0.215) 0.051 (0.054)
I/rI 25.27 (5.97) 7.97 (6.80)
Completeness (%) 93.11 (87.46) 97.84 (98.72)
Redundancy 3.7 (3.4) 3.5 (3.4)
Reﬁnement
Resolution (Å) 50 – 1.48 25.05 – 1.69
No. reﬂections 54,770 23,924
Rwork/Rfree 0.195/0.226 0.180/0.222
No. atoms 7,379 2,035
Protein 3,336 1,674
Ligand/ion 116 5
Water 583 356
B-factors 37.60 14.40
Protein 36.50 12.60
Ligand/ion
Water 46.00 22.80
R.m.s. deviations
Bond lengths (Å) 0.009 0.019
Bond angles () 1.39 1.79
Ramachandran plot
Most favored regions (%) 95.1 95.2
Additional allowed regions (%) 4.9 4.8
* Values in parentheses are for the highest-resolution shell.
a Rr.i.m., redundancy-independent merging R factor; Rp.i.m., precision-indicating
merging R factor [45].
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Diffraction data was collected at Photon Factory beamline BL-
5A (Japan), SPring-8 beamline BL26B1 (Japan), and Pohang Acceler-
ator Laboratory beamlines 5C and 7A (Korea). Data processing and
reduction were carried out using HKL2000 [31], iMoslfm [32] and
POINTLESS [33] and MOLPROBITY [34]. Open, ligand-free SpAdK
structure was solved by molecular replacement using PHENIX
[35] with AdK from Marinibacillus marinus (PDB ID: 3FB4) and
Burkholderia pseudomallei (PDB ID: 3GMT) as search models. Itera-
tive manual model building and reﬁnement were performed using
COOT [36] and PHENIX [35]. The structure of SpAdK:Ap5A in closed
conformation was solved by molecular replacement using open,
ligand-free SpAdK structure as the search model. Statistics for data
collection and structure reﬁnement are shown in Table 1.
4.4. Activity assay
Enzymatic activity of SpAdK was determined by monitoring
either ATP or ADP production. ATP production assay was performed
in buffer C (25 mM phosphate pH 7.2, 5 mMMgCl2, 65 mM KCl and
2 mM ADP). The buffer C was then preincubated at 37 C for 5 min
prior to the addition of SpAdK at the ﬁnal concentration of 10 nM.
The concentration of ATP was determined by following manufac-
turer’s instruction of ATP determination kit (Invitrogen). ADP pro-
duction from ATP and AMP was measured as described previously
[37]. Brieﬂy, the reaction buffer D for measuring ADP production
contained 25 mM phosphate pH 7.2, 5 mM MgCl2, 65 mM KCl,
0.12 mMNADH, 0.2 mMphosphoenolpyruvate, 10 units of both lac-
tate dehydrogenase/pyruvate kinase mixture, 1.4 mM AMP and
50 lM ATP. ADP concentration was determined by subtracting the
concentration of NADH consumed during the reaction from the
NADH concentration of the control. All reagents for the assay were
purchased from Sigma–Aldrich. Values shown are averaged ones
from independent experiments in at least triplicate.
4.5. Bacterial strains conditions
The bacterial strains of S. pneumoniae and plasmids used in this
study are shown in Table 2. Non-encapsulated S. pneumoniae
CP1200, a derivative of Rx1 [38] or encapsulated S. pneumoniae
D39 (serotype 2, NCTC7466) [39] was cultured in Casitone–tryp-
tone-based medium (CAT) or Todd-Hewitt broth containing yeast
extract (THY broth) as described previously [38,40]. Pneumococcal
competence was controlled by appropriate addition of the compe-
tence stimulating peptide-1 as described previously [41]. Erythro-
mycin (0.1 lg/ml) or tetracycline (1.0 lg/ml) was used to select
pneumococcal transformants.
4.6. Construction of a fucose-inducible adk strain
A S. pneumoniae D39 fucose-inducible adk strain (D39 PfcsK-adk;
TTL01) was constructed by replacing adk promoter with the PfcsK
inducible promoter in the chromosome of S. pneumoniae using a
triple joining PCR ampliﬁcation with overlapping primers (Table 3).
First, a cassette containing an erythromycin resistance marker
(ermAM), a fucose promoter (PfcsK), and transcriptional terminators
(t1,t2) that are located at the 50 end of the PfcsK promoter was
ampliﬁed from the Cheshire cassette, which was kindly provided
by Morrison [42], using primers ermAM-F and ermAM-R [43].
Two arms were ﬂanked by S. pneumoniae D39 DNA genome as fol-
lows: left arm contained a part of secY (upstream gene of adk) and
ended at its stop codon, and was ampliﬁed by primers adk1 and
adk2; right arm was initiated at adk start codon and forward
715 bp using primers adk3 and adk4. The cassette, left and right
arms were used as templates for a triple-joining PCR using primersadk1 and adk4. The PCR product was integrated homogenously
into S. pneumoniae D39 by transformation. The transformant was
selected by 0.1 lg/ml erythromycin and 0.5% L-()-fucose (Sigma)
and conﬁrmed by sequencing.
4.7. RNA isolation and qRT-PCR
S. pneumoniae D39 and TTL01 were cultured to exponential
phase prior to isolation of the RNA by hot phenol method as
described previously [43]. One microgram of bacterial RNA was
reverse transcribed into cDNA using a random primer (Takara)
and MLV-RT enzyme (SUPER Bio). Quantitative reverse transcrip-
tional PCR (qRT-PCR) was performed according to the manufac-
turer’s instructions (Intron). Each condition was analyzed in
triplicate.
4.8. Complementation test
For complementation test, adk wild-type or R89A mutant con-
taining their natural promoters were inserted into pET28a vector
(Novagen), then subcloned into pMV158 vector [43] by using Hin-
dIII and EcoRI restriction enzymes. The transformation of
pMV158::adk and pMV158::adk-R89A into S. pneumoniae D39
adk-inducible strains were performed as previously described.
The transformants were selected by 0.1 lg/ml erythromycin and
1.0 lg/ml tetracycline, and followed by colony PCR screening using
tetracycline resistance-speciﬁc primers for pMV158. Transfor-
mants were selected and then used for plasmid isolation. Recombi-
nant’s nucleotide sequence was identiﬁed by PCR with adk_HindIII
and adk_EcoRI primers and also conﬁrmed by sequencing.
4.9. Pneumococcal ATP determination
S. pneumoniaewas grown exponentially in THY with (0.1%, 0.5%,
and 1.0%) or without fucose until A550 = 0.5. Bacterial pellet was
Table 2
Pneumococcal strains and plasmids used in this study.
Strains plasmids Relevant characteristics Antibiotic resistance References
Strains
D39 Encapsulated, type 2 [39]
TTL01 D39 PfcsK::adk ERY This study
TTL02 TTL01 containing pMV158-adk ERY, TET This study
TTL03 TTL01 containing pMV158-adk-R89A ERY, TET This study
CP1200 Non-encapsulated derivative of Rx1 malM511-str1 [38]
TTL04 CP1200 PfcsK::adk ERY This study
TTL05 TTL02 containing pMV15-adk ERY, TET This study
TTL06 TTL02 containing pMV158-adk-R89A ERY, TET This study
Plasmids
pMV158 5300 bp, streptococcal plasmid TET [43]
Table 3
Primers used in this study.
Name Sequence (50 ? 30)
adk1 tac ctt ggc tgg agc tca at
adk2 tag gac tgc cta ccg aaa aat tat tct gtt ctg tcc atg a
adk3 gga cga aga gag aag aaa aat gaa tct ttt gat tat ggg
adk4 tcg att cga tcg ctc tag ac
ermAM-F ttt ttc ggt agg cag tcc tac cgt ggc tta ccg ttc gta tag
ermAM-R ttt tct tct ctc ttc gtc ctt ga
adk_HindIII ccc aag ctt atg aat ctt ttg att atg ggc tta
adk_EcoRI cga att ctt att tca aat ttg tca ata ctt ttt
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Determination Kit (Molecular Probes-Invitrogen). Quantitative
determination of ATP in S. pneumoniae is based on recombinant
ﬁreﬂy luciferase and L-luciferin reaction (luciferin + ATP + O2?
oxyluciferin + AMP + pyrophosphate + CO2 + light). Signals were
detected via Luminometer (Tunner Biosystem) and ATP amount
was quantiﬁed using an ATP standard curve.
4.10. Ethical statement for animal care and experiments
Male CD-1 (ICR) mice 4–5 weeks old (weighing approximately
20 g each, free-pathogens) were obtained from OrientBio Inc.
(Seongnam, Korea), and acclimatized for a week. The animals were
fed with water and sterile standard chow ad libitum. A speciﬁc
pathogen-free barrier facility (12 h light/dark cycle, 22 ± 2 C room
temperature, 50 ± 10% relative humidity) at the School of Phar-
macy at Sungkyunkwan University (Suwon, Korea) was used to
maintain the animals. All animal experiments conformed to the
animal care guidelines of the Korean Academy of Medical Sciences,
and infection procedures followed protocol PH-530518-06 that
was approved and monitored by the Animal Care and Use Commit-
tee of the Sungkyunkwan University (Suwon, Korea). For coloniza-
tion experiment, mice were anesthetized using ketamine solution
(80–100 mg/kg) prior to sacriﬁce for only blood collection.
For in vivo virulence test, mice (n = 14–15) were infected either
i.n. or i.p. with encapsulated D39 or its isogenic adk mutant TTL01
strain to evaluate effect of adk on pneumococcal survival and viru-
lence. Prior to infection, pneumococci were cultured in THY broth
in the presence of 0.5% or absence of fucose to approximately
A550 = 0.3 (1.5  108 CFU/ml). Mouse was infected i.n. or i.p. with
1.5  107 CFU per mouse. The survival of mice was recorded within
80 h for i.p. infection or 14 days for i.n. infection. After infection,
mice survival was monitored 8 times during ﬁrst 4 days and 4
times until the end of the experiment.
To determine colonization of the bacteria, mice (n = 5) were
infected with 1.5  104 CFU i.p. or 1.5  106 CFU i.n. Mice were
anesthetized using ketamine solution prior to sacriﬁce either at
24 h post-infection for i.p. infection or 48 h post-infection for i.n.
infection [44]. Viable cells number in the blood was counted afterserial dilution with phosphate buffer saline (PBS) prior to plating
onto THY blood agar for D39 or agar supplemented with 0.5% (w/
v) fucose and 0.1 lg/ml of erythromycin for TTL01.
4.11. Antisera and Western blot
Group of 5-week-old male CD1 mice (n = 5) were immunized
i.p. with 10 lg of puriﬁed SpAdK in combination with 100 lg of
aluminum adjuvant (Sigma) at 14-day intervals. Mice were anes-
thetized using ketamine solution, and sera was collected frommice
a week after the third immunization.
S. pneumoniae was grown exponentially in THY (A550 = 0.5) and
lysed in lysis buffer (50 mM Tris–Cl pH 8.0, 1 mM DTT, 0.1% Triton
X-100, 1 mM protease inhibitor). Total proteins were collected and
used for Western blot. Samples then were probed with appropriate
antibody diluted 1:1000 fold in Tris buffer saline (TBS) containing
0.1% Tween20 (Sigma). The secondary antibody was anti-mouse or
anti-rabbit immunoglobulin G conjugated with horse radish perox-
idase (HRP) diluted 1:10,000 fold with TBS containing 0.1%
Tween20 (Sigma).
4.12. Statistical analyses
Most of the graphs and statistical analyses were prepared using
SigmaPlot 11.0 software (Systat Software), except in vivo tests
(Fig. 8), which were prepared using GraphPad Prism version 5.02.
Statistical analysis was calculated using an appropriate One Way
ANOVA (Duncan’s method, non-parametric), Student’s t-test
(non-parametric), Mann Whitney U Test (non-parametric), or
Log-rank Test. A value of P 6 0.05 (denoted by ⁄), P 6 0.01 (denoted
by ⁄⁄) and P 6 0.001 (denoted by ⁄⁄⁄), was considered signiﬁcant.
Data presented are the mean SD of the mean for 2–4 independent
experiments.
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